ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 211 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,587,394 | -92.3% | 8,342 | -93.0% | 0.00% | -92.7% |
| Q1 2024 | $46,860,161 | +10.9% | 119,019 | +7.2% | 0.04% | -14.6% |
| Q4 2023 | $42,245,991 | +5.9% | 111,048 | +36.9% | 0.05% | -5.9% |
| Q3 2023 | $39,877,093 | +66.3% | 81,112 | +31.9% | 0.05% | +70.0% |
| Q2 2023 | $23,973,072 | +33.7% | 61,512 | +27.8% | 0.03% | +20.0% |
| Q1 2023 | $17,927,804 | -37.5% | 48,118 | -36.5% | 0.02% | -43.2% |
| Q4 2022 | $28,696,372 | -99.8% | 75,750 | +62.1% | 0.04% | +69.2% |
| Q3 2022 | $16,499,439,000 | +11701.6% | 46,734 | +12565.0% | 0.03% | – |
| Q2 2022 | $139,807,000 | -73.9% | 369 | -75.8% | 0.00% | -100.0% |
| Q4 2021 | $534,740,000 | -54.9% | 1,527 | -83.0% | 0.00% | -50.0% |
| Q1 2020 | $1,185,570,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |